REGISTERED
on 11 Jan 2022
Last Applicant/ Owned by
RM 802, 8F, 1BLD, WEST TOWER, 88,
SHANGHAI
CN
201210
Serial Number
88480086 filed on 19th Jun 2019
Registration Number
6615802 registered on 11th Jan 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
I-MAB
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
Classification Information
Class [005]
Pharmaceutical Products
Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
First Use Date in General
19th Dec 2018
First Use Date in Commerce
19th Dec 2018
Mark Details
Serial Number
No 88480086
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 54LW-298868
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th May 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 11th Jan 2022 | REGISTERED-PRINCIPAL REGISTER |
| 10th Dec 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 09th Dec 2021 | EXAMINERS AMENDMENT E-MAILED |
| 09th Dec 2021 | EXAMINER'S AMENDMENT ENTERED |
| 09th Dec 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 09th Dec 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 09th Dec 2021 | SU-EXAMINER'S AMENDMENT WRITTEN |
| 04th Dec 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th Dec 2021 | STATEMENT OF USE PROCESSING COMPLETE |